Ronald Richard

CIK: 0001380177

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EBS

Emergent BioSolutions Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

EBS
Emergent BioSolutions Inc.
Apr 30, 2026
Award(A)
Direct
25.3K shares-
EBS
Emergent BioSolutions Inc.
Dec 5, 2025
Sale(S)
Direct
7.1K shares at avg. $12.11$86K
EBS
Emergent BioSolutions Inc.
Dec 5, 2025
Exercise(M)
Direct
25.7K shares at avg. $5.02$129K
EBS
Emergent BioSolutions Inc.
Dec 5, 2025
Tax Payment(F)
Direct
10.9K shares at avg. $11.90$129K
EBS
Emergent BioSolutions Inc.
Dec 5, 2025
Sale(S)
Direct
14.9K shares at avg. $11.90$177K
EBS
Emergent BioSolutions Inc.
Apr 30, 2025
Award(A)
Direct
34.4K shares-

		Type	Shares	Price		Ownership
Apr 30, 2026	EBS Emergent BioSolutions Inc.	Award(A)	25,344	-	$0	Direct
Dec 5, 2025	EBS Emergent BioSolutions Inc.	Sale(S)	7,100	$12.11	$85,990	Direct
Dec 5, 2025	EBS Emergent BioSolutions Inc.	Exercise(M)	25,748	$5.02	$129,255	Direct
Dec 5, 2025	EBS Emergent BioSolutions Inc.	Tax Payment(F)	10,864	$11.90	$129,258	Direct
Dec 5, 2025	EBS Emergent BioSolutions Inc.	Sale(S)	14,884	$11.90	$177,087	Direct
Apr 30, 2025	EBS Emergent BioSolutions Inc.	Award(A)	34,403	-	-	Direct

1-6 of 6 transactions

About Richard Ronald

Richard Ronald (SEC CIK 0001380177) files insider reports with the SEC as Director of Emergent BioSolutions Inc. (EBS).

Signal8 holds 3 ownership filings by Richard Ronald, all Form 4s, filed between May 2, 2025 and May 4, 2026. Those filings report 6 transactions, from Apr 30, 2025 to Apr 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Richard Ronald's filings is in GAITHERSBURG, MD.

Recent filings by Richard Ronald

Apr 30, 2026: Grant or award of EBS shares (Form 4, code A).
Dec 5, 2025: Open-market sale of EBS shares (Form 4, code S).
Dec 5, 2025: Option exercise of EBS shares (Form 4, code M).
Dec 5, 2025: Tax withholding of EBS shares (Form 4, code F).
Dec 5, 2025: Open-market sale of EBS shares (Form 4, code S).

Other insiders filing for Emergent BioSolutions Inc. (EBS)

DeGolyer Donald W, Director
Williams Paul Anthony, SVP, Products Business
Duatschek Stephanie, EVP, CGO
LINDAHL RICHARD S, EVP, Chief Financial Officer
Glessner Coleen, EVP, Quality & Ethics, and CPL
Hartzel William, SVP, Bioservices

How to read Form 4 transaction codes